Angiotensin-converting enzyme inhibition with enalapril increases the cardiac concentration of vasoactive intestinal peptide

Annals of the New York Academy of Sciences

Volumn 805, Issue , 1996, Pages 713-716

  Duggan, K A ^a,b   Ye, V Z C ^a  

^a PRINCE HENRY HOSPITAL   (Australia)

^b Liverpool Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HEART; HEART FUNCTION; IMMUNOHISTOCHEMISTRY; INOTROPISM; KIDNEY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; TISSUE LEVEL;

EID: 0030453732     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17546.x     Document Type: Conference Paper

References (10)

1. UNVERFERTH, D. V., T. M. O'DORISO, M. M. MILLER, B. F. URETSKY, R. D. MAGORIEN, C. V. LEIER, M. E. THOMPSON & R. L. HAMLIN. 1986. J. Lab. Clin. Med. 108: 11-16.
2. BELL, D. & B. J. MCDERMOTT. 1994. J. Cardiovasc. Pharmacol. 23: 959-969.
3. UNVERFERTH, D. V., T. M. O'DORISO, W. W. MUIR, J. WHITE, M. M. MILLER, R. L. HAMLIN & R. D. MAGORIEN. 1985. J. Lab. Clin. Med. 106: 542-550.
4. DUGGAN, K. A., D. M. JONES, V. Z. C. YE, R. E. DAVIS & G. J. MACDONALD. 1995. Clin. Sci. 89: 267-271.
5. DAVIS, R. E., S. SHELLEY, G. J. MACDONALD & K. A. DUGGAN. 1992. J. Physiol. 451: 17-23.
6. WEIHE, E., M. REINECKE & W. G. FORSMAN. 1984. Cell Tissue Res. 236: 527-540.
7. HERSHBERGER, R. E., F. L. ANDERSON & M. R. BRISTOW. 1989. Circ. Res. 65: 283-294.
8. KOCHE-WESER, J. 1964. Circ. Res. 14: 337-342.
9. HERMSMEYER, K. & O. APRILLIGLIANO. 1976. Am. J. Physiol. 230: 306-310.
10. MANZINI, S., F. PERRETTI, L. DE BENDETTI, P. PRADELLES, C. A. MAGGI & P. GEPPETTI. 1989. Br. J. Pharmacol. 97: 303-312.